MCQOPTIONS
Saved Bookmarks
| 1. |
Which of the following has approved the trial of a drug, developed by Cadila Pharmaceuticals Ltd., for reducing the mortality rate in critically ill COVID-19 patients? |
| A. | Ministry of AYUSH |
| B. | National Institute of Standards and Technology |
| C. | Ministry of Health and Family Welfare |
| D. | Drugs Controller General of India |
| E. | Indian Council of Medical Research |
| Answer» E. Indian Council of Medical Research | |